Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo

Author: Friedberg J.W.   Dong D.A.   Li S.   Kim H.   Stephans K.   Noonan K.   Neuberg D.   Gribben J.G.   Fisher D.C.   Freedman A.S.   Takvorian T.   Jurgens R.   Battle T.E.   Frank D.A.  

Publisher: Elsevier

ISSN: 0145-2126

Source: Leukemia Research, Vol.28, Iss.2, 2004-02, pp. : 139-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content